We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


JSR Expands its Biomedical Business by Investing in BIA Separations' Unique Purification Technology

Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "JSR Expands its Biomedical Business by Investing in BIA Separations' Unique Purification Technology"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

From JSR’s perspective, teaming up with BIA Separations will give JSR access to a unique and leading edge technology in the field of downstream purification of large bio-molecules. Combining this technology with JSR’s proprietary Protein A media, we offer the bio pharmaceutical industry a faster, more reliable downstream purification process at a lower cost of ownership. This will contribute to making advanced treatments accessible to a larger part of the human society.

BIA Separations recognizes that JSR Corporation is a leading polymer chemistry manufacturer with a very strong commitment to the life sciences industry. JSR’s global presence in the local markets and JSR’s expertise in the field of consistent high quality volume manufacturing will help BIA Separations to successfully grow its business while maintaining its technological leadership. This partnership is a very important message to the industry as it secures the long term presence of BIA Separations and its technology and products on the market.